Focus: Philips is a Dutch multinational medical devices and healthcare technology company with 10,000+ employees, headquartered in Amsterdam. The company operates across imaging, monitoring, and therapeutic device categories with a diverse portfolio spanning cardiology, respiratory, and oncology.
Profile data last refreshed 1h ago · AI intelligence enriched 3w ago
No open roles listed right now. Follow Philips to get notified when they start hiring — the background below is worth knowing for when they do.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Multiple variants (Auto, AutoSV Advanced, Synchrony) indicate mature, high-volume respiratory franchise supporting recurring patient adherence.
Help build intelligence for Philips
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Philips's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Phase 3 validation for uterine fibroids indicates targeted advancement; image-guided intervention represents high-margin specialty application.
Multiple AI-enhanced reconstruction algorithms and deep-learning features suggest continuous platform evolution maintaining competitive moat.
Multiple catheter-based platforms with novel imaging guidance (electromagnetic tracking, KODEX-EPD) position Philips as interventional procedure enabler.
8-K Filing: TuHURA Biosciences, Inc./NV (HURA) (CIK 0001498382) — 8-K
8-K
8-K Filing: KPET Ultra Paceline Corp (CIK 0002095297) — CURRENT REPORT
CURRENT REPORT
8-K Filing: Beyond Air, Inc. (XAIR) (CIK 0001641631) — EX-99.1
EX-99.1
8-K Filing: Wells Fargo Commercial Mortgage Trust 2026-C66 (CIK 0002109197) — POOLING AND SERVICING AGREEMENT, DATED AS OF FEBRUARY 1, 2026
POOLING AND SERVICING AGREEMENT, DATED AS OF FEBRUARY 1, 2026
8-K Filing: Milestone Pharmaceuticals Inc. (MIST) (CIK 0001408443) — FORM 8-K
FORM 8-K
8-K Filing: BAXTER INTERNATIONAL INC (BAX) (CIK 0000010456) — EX-99.1
EX-99.1
Showing 6 of 10 news items
No open positions listed yet. Check their careers page directly.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles
Recent peer-reviewed publications with author affiliations at this company
Showing 5 of 10 publications